Intervention

Piflufolastat F18

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions7

Lead sponsors shown2

Clinical trials

3 shown

Ultralow Dose PET Imaging for PSMA ExpressionNCT06904313 · 2025-05-12

A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical ProstatectomyNCT06085664 · 2023-12-04

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerNCT05394259 · 2022-10-28

ACTIVE_NOT_RECRUITING

Common conditions

Breast Cancer1 Healthy Volunteer1 Hepatocellular Carcinoma1 Pancreatic Cancer1 Prostate CA1 Prostate Cancer1 Radical Prostatectomy1

Leading sponsors

M.D. Anderson Cancer Center2 Akiva Mintz1

Trial status mix

RECRUITING2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.